In addition, the CSF levels of both GAP-43 and SYT1 significantly increased in patients with dementia due to AD, implying that these genes can potentially be used as biomarkers of synaptic dysfunction to predict the progression of AD (Öhrfelt et al., 2016; Qiang et al., 2022). Here, SYT1 is linked to Alzheimer disease.